Letter by Chen et al Regarding Article, “Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.